- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02589509
Cognitive Rehabilitation and Brain Activity of Attention Control in TBI
February 3, 2022 updated by: VA Office of Research and Development
Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI
The purpose of this study is to test an innovative combination of direct-attention training and metacognitive training in the treatment of attention impairments in Veterans with moderate-to-severe traumatic brain injury (TBI) who report experiencing attentional problems.
Enrolled participants will be randomized to receive either the direct-attention training or metacognitive training first and then will be crossed over to receive the opposite intervention.
The study will consist of two treatment periods of 4 weeks and a post-treatment 4 weeks later.
In addition to the rehabilitation treatments, participants will also perform measures of complex functional activities (e.g., independent activities of daily living or IADLs) and neurocognitive tests of attention-control functions.
Participants will also perform an attentional task that probes the function of three different attentional systems while brain wave activity (i.e., electroencephalography or EEG) is being recorded in order to assess changes in brain function that may be improved by the rehabilitation approach.
Planned enrollment will be 36 Veterans.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
Attention impairment is ubiquitous in TBI survivors.
This is a devastating impairment because attention is the backbone of cognitive systems.
Attention is requisite for other cognitive processes that are vital to everyday functioning such as memory, problem solving, language skills, and the cognitive control of behavior.
Studies of attention training have shown improved attention on laboratory measures, but limited translation to real-world tasks.
Notably, these previously-tested rehabilitation approaches have not included training in the very cognitive processes needed for translation of training to everyday tasks which include internal verbalization and self-monitoring, also called metacognitive strategies.
One training method for metacognitive strategies has shown promise, but is lacking in basic attention training.
Rehabilitation specialists have recently argued for a rehabilitation approach wherein both basic foundational attention and metacognitive strategies should be synergistically combined.
Consequently, the investigators will test an innovative combination of direct-attention training and metacognitive training for which the other compensates disadvantages of each.
Because of the promise of each type of training separately, and the potential additive effects of the combination, it is critical to test this combined attention and metacognitive training in Veteran survivors of chronic moderate-to-severe traumatic brain injury (TBI).
The investigators will address the following two specific aims: the investigators propose to conduct a pilot study to examine cognitive rehabilitation therapy (CRT) effects in a group of Veterans with chronic moderate to severe TBI (m/sTBI), focused on remediating attention-control impairments using both direct-attention and metacognitive-strategy training approaches in a AB/BA crossover design with 1-month follow-up to address the following two specific aims: 1) Test treatment response to combined direct-attention and metacognitive-strategy training in Veterans with chronic m/sTBI; and 2) identify mechanisms and biomarkers of rehabilitation-related neuroplasticity.
Under the first aim the investigators will test for effects of combined direct-attention and metacognitive-strategy training on measures of complex functional activities and neurocognitive tests of attention-control functions.
Under the second aim, the investigators will test effects of the their CRT approach on behavioral and brain activity while participants perform a well-validated attentional task that probes the function of three dissociable attentional systems.
The approach is innovative because it combines a theoretically motivated and novel approach to address a significant source of disability in Veteran survivors of TBI.
The proposed research is significant because findings will form the foundation for a larger-scale trial to enable us to determine the durability of gains and the functional impact of treatment on Veteran's real world activities and to more positively shape healthcare for our Veterans who are suffering from TBI. Outcome measures will include standardized tests of neurocognitive functioning such as attention and other cognitive skills, measures of self care, ability to live independently, social role participation, life satisfaction, TBI-related quality of life, mood/anxiety, and attention-related scalp-recorded brain event-related potentials (ERPs, derived from electroencephalography).
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32608
- North Florida/South Georgia Veterans Health System, Gainesville, FL
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- OEF/OIF/OND Veterans with moderate or severe TBI as described by DOD/VA common definition.
- Self-report of attentional problems, confirmed with psychometric testing.
- Ruff 2 & 7 selective attention task score <= 1.5 standard deviations from demographically-matched norms.
- Able to participate in study at 12-60 months post injury without contraindications.
- Age 21-55 years.
- Willingness to be randomized and to participate in treatment procedures.
- Capacity to visit the laboratory for repeated treatment and testing sessions.
- Access to internet-enabled home computer.
- English as Native language.
- Adequate reading comprehension to allow completion of study-related questionnaires.
- Reliable digit span (RDS) score > 7.
Exclusion Criteria:
- Pre-existing neurological disorder associated with cerebral dysfunction (e.g., stroke, history of epilepsy or chronic seizure disorder).
- Current alcohol or drug use/dependence.
- Pre-existing severe psychiatric disorder (e.g., schizophrenia, bipolar disorder) or history of psychiatric diagnosis sufficiently severe to have resulted in inpatient hospitalization.
- Current suicidal or homicidal ideation.
- Reported involvement in current litigation.
- Reported history of pre-injury learning disability.
- Not competent to provide written informed consent (i.e., not able to demonstrate understanding or expectations of study and potential risks of participation).
- Does not fully understand the nature of the study and requirements of participation.
- Does not understand task instructions.
- Validity testing score on RDS <= 7.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Direct-Metacognitive
Direct attention training followed by metacognitive strategy training
|
BrainHQ (by Posit Science Corp.) computerized attention training using the following modules: "Divided attention," "Target tracker," "Double Decision," "Mixed Signals," and "Freeze Frame."
A compensatory metacognitive strategy-based intervention program that teaches strategies for improving attentional control and problem solving.
|
|
Experimental: Metacognitive-Direct
Metacognitive strategy training followed by direct-attention training
|
BrainHQ (by Posit Science Corp.) computerized attention training using the following modules: "Divided attention," "Target tracker," "Double Decision," "Mixed Signals," and "Freeze Frame."
A compensatory metacognitive strategy-based intervention program that teaches strategies for improving attentional control and problem solving.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Timed Instrumental Activities of Daily Living (TIADL)
Time Frame: Baseline TIADL Reaction Time assessed pretreatment
|
The TIADL is a timed, performance-based measure of everyday cognition/instrumental activities of daily living (IADLs) in which participants are presented with common everyday stimuli (e.g., medication labels, transportation schedules, cake-mix ingredients, phone book) and asked to answer questions.
The dependent variables are the number of accurate responses and response speed to each accurate item is recorded.
|
Baseline TIADL Reaction Time assessed pretreatment
|
|
Timed Instrumental Activities of Daily Living (TIADL)
Time Frame: Change from Baseline in TIADL Reaction Time assessed at 8 weeks
|
The TIADL is a timed, performance-based measure of everyday cognition/instrumental activities of daily living (IADLs) in which participants are presented with common everyday stimuli (e.g., medication labels, transportation schedules, cake-mix ingredients, phone book) and asked to answer questions.
The dependent variables are the number of accurate responses and response speed to each accurate item is recorded.
|
Change from Baseline in TIADL Reaction Time assessed at 8 weeks
|
|
Timed Instrumental Activities of Daily Living (TIADL)
Time Frame: Change from Baseline in TIADL Reaction Time assessed at 12 weeks (1-month post treatment)
|
The TIADL is a timed, performance-based measure of everyday cognition/instrumental activities of daily living (IADLs) in which participants are presented with common everyday stimuli (e.g., medication labels, transportation schedules, cake-mix ingredients, phone book) and asked to answer questions.
The dependent variables are the number of accurate responses and response speed to each accurate item is recorded.
|
Change from Baseline in TIADL Reaction Time assessed at 12 weeks (1-month post treatment)
|
|
Timed Instrumental Activities of Daily Living (TIADL) - Accuracy
Time Frame: Change from Baseline in TIADL Accuracy assessed at 4 weeks
|
The TIADL is a timed, performance-based measure of everyday cognition/instrumental activities of daily living (IADLs) in which participants are presented with common everyday stimuli (e.g., medication labels, transportation schedules, cake-mix ingredients, phone book) and asked to answer questions.
The dependent variables are the number of accurate responses and response speed to each accurate item is recorded.
|
Change from Baseline in TIADL Accuracy assessed at 4 weeks
|
|
Timed Instrumental Activities of Daily Living (TIADL) - Accuracy
Time Frame: Change from Baseline in TIADL Accuracy assessed at 8 weeks
|
The TIADL is a timed, performance-based measure of everyday cognition/instrumental activities of daily living (IADLs) in which participants are presented with common everyday stimuli (e.g., medication labels, transportation schedules, cake-mix ingredients, phone book) and asked to answer questions.
The dependent variables are the number of accurate responses and response speed to each accurate item is recorded.
|
Change from Baseline in TIADL Accuracy assessed at 8 weeks
|
|
Timed Instrumental Activities of Daily Living (TIADL) - Accuracy
Time Frame: Change from Baseline in TIADL Accuracy assessed at 12 weeks (1 month post treatment)
|
The TIADL is a timed, performance-based measure of everyday cognition/instrumental activities of daily living (IADLs) in which participants are presented with common everyday stimuli (e.g., medication labels, transportation schedules, cake-mix ingredients, phone book) and asked to answer questions.
The dependent variables are the number of accurate responses and response speed to each accurate item is recorded.
|
Change from Baseline in TIADL Accuracy assessed at 12 weeks (1 month post treatment)
|
|
Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Ability Score
Time Frame: Change from Baseline in MPAI-4 Ability Score assessed at 4 weeks
|
Assesses global outcome, including ability, adjustment and community participation indices.
|
Change from Baseline in MPAI-4 Ability Score assessed at 4 weeks
|
|
Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Ability Score
Time Frame: Change from Baseline in MPAI-4 Ability Score assessed at 8 weeks
|
Assesses global outcome, including ability, adjustment and community participation indices.
|
Change from Baseline in MPAI-4 Ability Score assessed at 8 weeks
|
|
Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Ability Score
Time Frame: Change from Baseline in MPAI-4 Ability Score assessed at 12 weeks (1 month post treatment)
|
Assesses global outcome, including ability, adjustment and community participation indices.
|
Change from Baseline in MPAI-4 Ability Score assessed at 12 weeks (1 month post treatment)
|
|
Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Adjustment Score
Time Frame: Change from Baseline in MPAI-4 Adjustment Score assessed at 4 weeks
|
Assesses global outcome, including ability, adjustment and community participation indices.
|
Change from Baseline in MPAI-4 Adjustment Score assessed at 4 weeks
|
|
Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Adjustment Score
Time Frame: Change from Baseline in MPAI-4 Adjustment Score assessed at 8 weeks
|
Assesses global outcome, including ability, adjustment and community participation indices.
|
Change from Baseline in MPAI-4 Adjustment Score assessed at 8 weeks
|
|
Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Adjustment Score
Time Frame: Change from Baseline in MPAI-4 Adjustment Score assessed at 12 weeks (1 month post treatment)
|
Assesses global outcome, including ability, adjustment and community participation indices.
|
Change from Baseline in MPAI-4 Adjustment Score assessed at 12 weeks (1 month post treatment)
|
|
Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Participation Score
Time Frame: Change from Baseline in MPAI-4 Participation Score assessed at 4 weeks
|
Assesses global outcome, including ability, adjustment and community participation indices.
|
Change from Baseline in MPAI-4 Participation Score assessed at 4 weeks
|
|
Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Participation Score
Time Frame: Change from Baseline in MPAI-4 Participation Score assessed at 8 weeks
|
Assesses global outcome, including ability, adjustment and community participation indices.
|
Change from Baseline in MPAI-4 Participation Score assessed at 8 weeks
|
|
Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Participation Score
Time Frame: Change from Baseline in MPAI-4 Participation Score assessed at 12 weeks (1 month post treatment)
|
Assesses global outcome, including ability, adjustment and community participation indices.
|
Change from Baseline in MPAI-4 Participation Score assessed at 12 weeks (1 month post treatment)
|
|
Timed Instrumental Activities of Daily Living (TIADL) - Reaction Time score
Time Frame: Baseline (pretreatment) on TIADL - Reaction Time score
|
The TIADL is a timed, performance-based measure of everyday cognition/instrumental activities of daily living (IADLs) in which participants are presented with common everyday stimuli (e.g., medication labels, transportation schedules, cake-mix ingredients, phone book) and asked to answer questions.
The dependent variables are the number of accurate responses and response speed to each accurate item is recorded.
|
Baseline (pretreatment) on TIADL - Reaction Time score
|
|
Timed Instrumental Activities of Daily Living (TIADL) - Accuracy score
Time Frame: Baseline (pretreatment) on TIADL - Accuracy score
|
The TIADL is a timed, performance-based measure of everyday cognition/instrumental activities of daily living (IADLs) in which participants are presented with common everyday stimuli (e.g., medication labels, transportation schedules, cake-mix ingredients, phone book) and asked to answer questions.
The dependent variables are the number of accurate responses and response speed to each accurate item is recorded.
|
Baseline (pretreatment) on TIADL - Accuracy score
|
|
Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4)
Time Frame: Baseline (pretreatment) MPAI-4 Adjustment score
|
Assesses global outcome, including ability, adjustment and community participation indices.
The MPAI-4 is a 35-item questionnaire-based inventory that will be completed study staff and TBI survivors.
It offers three subscales (Ability, Adjustment, and Participation) and has well-documented psychometric properties.
MPAI-4 items represent the range of physical, cognitive, emotional, behavioral, and societal problems that TBI survivors often encounter; it also assess major obstacles to community integration.
|
Baseline (pretreatment) MPAI-4 Adjustment score
|
|
Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4)
Time Frame: Baseline (pretreatment) MPAI-4 Participation score
|
Assesses global outcome, including ability, adjustment and community participation indices.
The MPAI-4 is a 35-item questionnaire-based inventory that will be completed study staff and TBI survivors.
It offers three subscales (Ability, Adjustment, and Participation) and has well-documented psychometric properties.
MPAI-4 items represent the range of physical, cognitive, emotional, behavioral, and societal problems that TBI survivors often encounter; it also assess major obstacles to community integration.
|
Baseline (pretreatment) MPAI-4 Participation score
|
|
Attention Network Test (ANT) Alerting Reaction Time score
Time Frame: Change from Baseline in Altering Reaction Time Score assessed at 4 weeks
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Change from Baseline in Altering Reaction Time Score assessed at 4 weeks
|
|
Attention Network Test (ANT) Alerting Reaction Time score
Time Frame: Change from Baseline in Altering Reaction Time Score assessed at 8 weeks
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Change from Baseline in Altering Reaction Time Score assessed at 8 weeks
|
|
Attention Network Test (ANT) Alerting Reaction Time score
Time Frame: Change from Baseline in Altering Reaction Time Score assessed at 12 weeks (1 month post treatment)
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Change from Baseline in Altering Reaction Time Score assessed at 12 weeks (1 month post treatment)
|
|
Attention Network Test (ANT) Orient Reaction Time score
Time Frame: Baseline (pretreatment) Orienting Reaction Time score
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Baseline (pretreatment) Orienting Reaction Time score
|
|
Attention Network Test (ANT) Orienting Reaction Time score
Time Frame: Change from Baseline in Orienting Reaction Time Score assessed at 4 weeks
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Change from Baseline in Orienting Reaction Time Score assessed at 4 weeks
|
|
Attention Network Test (ANT) Orienting Reaction Time score
Time Frame: Change from Baseline in Orienting Reaction Time Score assessed at 8 weeks
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Change from Baseline in Orienting Reaction Time Score assessed at 8 weeks
|
|
Attention Network Test (ANT) Orienting Reaction Time score
Time Frame: Change from Baseline in Orienting Reaction Time Score assessed at 12 weeks (1 month post treatment)
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Change from Baseline in Orienting Reaction Time Score assessed at 12 weeks (1 month post treatment)
|
|
Attention Network Test (ANT) Executive-Control Reaction Time score
Time Frame: Baseline (pretreatment) Executive-Control Reaction Time score
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Baseline (pretreatment) Executive-Control Reaction Time score
|
|
Attention Network Test (ANT) Executive-Control Reaction Time score
Time Frame: Change from Baseline in Executive-Control Reaction Time Score assessed at 4 weeks
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Change from Baseline in Executive-Control Reaction Time Score assessed at 4 weeks
|
|
Attention Network Test (ANT) Executive-Control Reaction Time score
Time Frame: Change from Baseline in Executive-Control Reaction Time Score assessed at 8 weeks
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Change from Baseline in Executive-Control Reaction Time Score assessed at 8 weeks
|
|
Attention Network Test (ANT) Executive-Control Reaction Time score
Time Frame: Change from Baseline in Executive-Control Reaction Time Score assessed at 12 weeks (1 month post treatment)
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Change from Baseline in Executive-Control Reaction Time Score assessed at 12 weeks (1 month post treatment)
|
|
Attention Network Test (ANT) Alerting Reaction Time score
Time Frame: Baseline (pretreatment) Alerting Reaction Time score
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Baseline (pretreatment) Alerting Reaction Time score
|
|
ANT ERP (N1) Alerting Amplitude
Time Frame: Baseline ANT ERP (N1) Alerting Amplitude assessed pretreatment
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Baseline ANT ERP (N1) Alerting Amplitude assessed pretreatment
|
|
ANT ERP (N1) Alerting Amplitude
Time Frame: Change from Baseline in ANT ERP (N1) Alerting Amplitude assessed at 4 weeks
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Change from Baseline in ANT ERP (N1) Alerting Amplitude assessed at 4 weeks
|
|
ANT ERP (N1) Alerting Amplitude
Time Frame: Change from Baseline in ANT ERP (N1) Alerting Amplitude assessed at 8 weeks
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Change from Baseline in ANT ERP (N1) Alerting Amplitude assessed at 8 weeks
|
|
ANT ERP (N1) Alerting Amplitude
Time Frame: Change from Baseline in ANT ERP (N1) Alerting Amplitude assessed at 12 weeks (1 month post treatment)
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Change from Baseline in ANT ERP (N1) Alerting Amplitude assessed at 12 weeks (1 month post treatment)
|
|
ANT ERP (N1) Orienting Amplitude
Time Frame: Baseline ANT ERP (N1) Orienting Amplitude assessed pretreatment
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Baseline ANT ERP (N1) Orienting Amplitude assessed pretreatment
|
|
ANT ERP (N1) Orienting Amplitude
Time Frame: Change from Baseline in ANT ERP (N1) Orienting Amplitude assessed at 4 weeks
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Change from Baseline in ANT ERP (N1) Orienting Amplitude assessed at 4 weeks
|
|
ANT ERP (N1) Orienting Amplitude
Time Frame: Change from Baseline in ANT ERP (N1) Orienting Amplitude assessed at 8 weeks
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Change from Baseline in ANT ERP (N1) Orienting Amplitude assessed at 8 weeks
|
|
ANT ERP (N1) Orienting Amplitude
Time Frame: Change from Baseline in ANT ERP (N1) Orienting Amplitude assessed at 12 weeks (1 month post treatment)
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Change from Baseline in ANT ERP (N1) Orienting Amplitude assessed at 12 weeks (1 month post treatment)
|
|
ANT ERP (P3) Executive Amplitude
Time Frame: Baseline ANT ERP (P3) Executive Amplitude assessed pretreatment
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Baseline ANT ERP (P3) Executive Amplitude assessed pretreatment
|
|
ANT ERP (P3) Executive Amplitude
Time Frame: Baseline ANT ERP (P3) Executive Amplitude assessed at 4 weeks
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Baseline ANT ERP (P3) Executive Amplitude assessed at 4 weeks
|
|
ANT ERP (P3) Executive Amplitude
Time Frame: Baseline ANT ERP (P3) Executive Amplitude assessed at 8 weeks
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Baseline ANT ERP (P3) Executive Amplitude assessed at 8 weeks
|
|
ANT ERP (P3) Executive Amplitude
Time Frame: Baseline ANT ERP (P3) Executive Amplitude assessed at 12 weeks (1 month post treatment)
|
The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm.
Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.
|
Baseline ANT ERP (P3) Executive Amplitude assessed at 12 weeks (1 month post treatment)
|
|
Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Ability Score
Time Frame: Baseline MPAI-4 Ability Score assessed pretreatment
|
Assesses global outcome, including ability, adjustment and community participation indices.
The MPAI-4 is a 35-item questionnaire-based inventory that will be completed study staff and TBI survivors.
It offers three subscales (Ability, Adjustment, and Participation) and has well-documented psychometric properties.
MPAI-4 items represent the range of physical, cognitive, emotional, behavioral, and societal problems that TBI survivors often encounter; it also assess major obstacles to community integration.
|
Baseline MPAI-4 Ability Score assessed pretreatment
|
|
Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Adjustment Score
Time Frame: Baseline MPAI-4 Adjustment Score assessed pretreatment
|
Assesses global outcome, including ability, adjustment and community participation indices.
The MPAI-4 is a 35-item questionnaire-based inventory that will be completed study staff and TBI survivors.
It offers three subscales (Ability, Adjustment, and Participation) and has well-documented psychometric properties.
MPAI-4 items represent the range of physical, cognitive, emotional, behavioral, and societal problems that TBI survivors often encounter; it also assess major obstacles to community integration.
|
Baseline MPAI-4 Adjustment Score assessed pretreatment
|
|
Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Participation Score
Time Frame: Baseline MPAI-4 Participation Score assessed pretreatment
|
Assesses global outcome, including ability, adjustment and community participation indices.
The MPAI-4 is a 35-item questionnaire-based inventory that will be completed study staff and TBI survivors.
It offers three subscales (Ability, Adjustment, and Participation) and has well-documented psychometric properties.
MPAI-4 items represent the range of physical, cognitive, emotional, behavioral, and societal problems that TBI survivors often encounter; it also assess major obstacles to community integration.
|
Baseline MPAI-4 Participation Score assessed pretreatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mindful Attention Awareness Scale-Lapses Only (MAAS-LO)
Time Frame: Change from Baseline in MAAS-LO Score assessed at 4 weeks
|
The MAAS-LO is a 12-item 6-point Likert-type scale designed to measure everyday attentional lapses (infrequent to very frequent).
|
Change from Baseline in MAAS-LO Score assessed at 4 weeks
|
|
Mindful Attention Awareness Scale-Lapses Only (MAAS-LO)
Time Frame: Change from Baseline in MAAS-LO Score assessed at 8 weeks
|
The MAAS-LO is a 12-item 6-point Likert-type scale designed to measure everyday attentional lapses (infrequent to very frequent).
|
Change from Baseline in MAAS-LO Score assessed at 8 weeks
|
|
Mindful Attention Awareness Scale-Lapses Only (MAAS-LO)
Time Frame: Change from Baseline in MAAS-LO Score assessed at 12 weeks (1 month post treatment)
|
The MAAS-LO is a 12-item 6-point Likert-type scale designed to measure everyday attentional lapses (infrequent to very frequent).
|
Change from Baseline in MAAS-LO Score assessed at 12 weeks (1 month post treatment)
|
|
Satisfaction with Life Scale (SWLS)
Time Frame: Baseline SWLS Score assessed pretreatment
|
The SWLS assesses patient's perceived satisfaction with life.
It is a 5-item 7-point Likert-type scale with a range from "strongly disagree" to "strongly agree."
The total score is used as a measure of satisfaction with life.
|
Baseline SWLS Score assessed pretreatment
|
|
Mindful Attention Awareness Scale-Lapses Only (MAAS-LO)
Time Frame: Baseline (pretreatment) on MAAS-LO
|
The MAAS-LO is a 12-item 6-point Likert-type scale designed to measure everyday attentional lapses (infrequent to very frequent).
|
Baseline (pretreatment) on MAAS-LO
|
|
Satisfaction with Life Scale (SWLS)
Time Frame: Change from Baseline in SWLS Score assessed at 4 weeks
|
The SWLS assesses patient's perceived satisfaction with life.
It is a 5-item 7-point Likert-type scale with a range from "strongly disagree" to "strongly agree."
The total score is used as a measure of satisfaction with life.
|
Change from Baseline in SWLS Score assessed at 4 weeks
|
|
Satisfaction with Life Scale (SWLS)
Time Frame: Change from Baseline in SWLS Score assessed at 8 weeks
|
The SWLS assesses patient's perceived satisfaction with life.
It is a 5-item 7-point Likert-type scale with a range from "strongly disagree" to "strongly agree."
The total score is used as a measure of satisfaction with life.
|
Change from Baseline in SWLS Score assessed at 8 weeks
|
|
Satisfaction with Life Scale (SWLS)
Time Frame: Change from Baseline in SWLS Score assessed at 12 weeks (1 month post treatment)
|
The SWLS assesses patient's perceived satisfaction with life.
It is a 5-item 7-point Likert-type scale with a range from "strongly disagree" to "strongly agree."
The total score is used as a measure of satisfaction with life.
|
Change from Baseline in SWLS Score assessed at 12 weeks (1 month post treatment)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ruff 2 & 7 Selective Attention Task (RSAT)
Time Frame: Eligibility screening (Pretreatment)
|
Psychometric validation/measurement of participant's subjective complaint of attention disturbance
|
Eligibility screening (Pretreatment)
|
|
Reliable Digit Span (RDS)
Time Frame: Eligibility screening (Pretreatment)
|
The Reliable Digit Span (RDS) test, scored from the forward and backward digit span from the Wechsler Adult Intelligence Scale version 4 (WAIS-IV), will be used to determine the potential presence of suboptimal effort; cutoff for the RDS will be a score 7.
|
Eligibility screening (Pretreatment)
|
|
Mental Health Screening Form 3rd edition (MHSF-III)
Time Frame: Eligibility screening (Pretreatment)
|
The MHSF-III is a structured interview that will be used to screen for the presence of exclusionary major psychopathology.
|
Eligibility screening (Pretreatment)
|
|
Wide Range Achievement Test, 4th edition (WRAT-4; word-reading subtest)
Time Frame: Group matching (Pretreatment)
|
The word-reading subtest of the WRAT-4 will administered to obtain a measure of estimated premorbid cognitive functioning, and groups will be matched, on average, for scores on this test.
|
Group matching (Pretreatment)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: William M Perlstein, PhD, North Florida/South Georgia Veterans Health System, Gainesville, FL
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2015
Primary Completion (Actual)
October 31, 2018
Study Completion (Actual)
October 31, 2018
Study Registration Dates
First Submitted
October 13, 2015
First Submitted That Met QC Criteria
October 26, 2015
First Posted (Estimate)
October 28, 2015
Study Record Updates
Last Update Posted (Actual)
February 15, 2022
Last Update Submitted That Met QC Criteria
February 3, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- N1920-P
- I21RX001920-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Injuries, Traumatic
-
Fondazione per la Ricerca Ospedale MaggioreCompletedBrain Injuries, Traumatic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateItaly
-
Hospital Sirio-LibanesUniversity of Sao Paulo; Ministry of Health, Brazil; Hospital Sao Rafael; PROAD... and other collaboratorsRecruitingBrain Injury Traumatic Severe | Brain Injury Traumatic Moderate | Post Traumatic EpilepsyBrazil
-
Technical University of MunichFederal Ministry of Defence (Germany); Bundesministerium der VerteidigungRecruitingTraumatic Brain InjuriesFrance, Germany
-
Direction Centrale du Service de Santé des ArméesRecruitingTraumatic Brain InjuriesFrance
-
Eunice Kennedy Shriver National Institute of Child...CompletedTraumatic Brain Injuries
-
Children's Hospital Medical Center, CincinnatiUniversity of CincinnatiCompletedBrain Injury Traumatic MildUnited States
-
All India Institute of Medical Sciences, JodhpurIndian Council of Medical Research; Post Graduate Institute of Medical Education... and other collaboratorsRecruitingSeizures | Traumatic Brain Injuries | Traumatic Brain Injury (TBI) PatientsIndia
-
University of Alabama at BirminghamCompletedTraumatic Brain InjuriesUnited States
-
University of TurkuTurku University Hospital; The Finnish Funding Agency for Technology and Innovation... and other collaboratorsCompletedBrain Injuries | TBI (Traumatic Brain Injury) | Brain Injuries, Traumatic | Traumatic Brain Injury | Injury, Brain, TraumaticFinland
-
Cambridge University Hospitals NHS Foundation TrustNot yet recruitingInjuries, Head | Traumatic Brain Injuries
Clinical Trials on Direct-attention training using web-based BrainHQ
-
University of MiamiUnited States Department of DefenseTerminated
-
Istanbul Medipol University HospitalUnknownObesity | StudentsTurkey
-
Posit Science CorporationNational Institute of Mental Health (NIMH)CompletedSchizophreniaUnited States
-
Arizona State UniversityUniversity of Colorado, Denver; University of New MexicoUnknownChildhood Obesity | Childhood OverweightUnited States
-
Umeå UniversityKarlstad UniversityRecruitingParkinson Disease | Cognitive ImpairmentSweden
-
University of UtahTerminated
-
Taipei Medical UniversityUnknown
-
University of MichiganCompletedSchizophrenia | Bipolar Disorder | Schizo Affective DisorderUnited States
-
DoczeroAmbulance OostUnknownImprovement of BLS/AED Training Methods
-
Rutgers, The State University of New JerseyNational Institute on Aging (NIA)RecruitingAlzheimer's Disease (AD) | Healthy AgingUnited States